Virax Biolabs Group Limited (VRAX) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Virax Biolabs Group Limited (VRAX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $526,283, listed on NASDAQ, employing roughly 26 people, carrying a beta of 1.34 to the broader market. Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Led by James Foster, public since 2022-07-21.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for VRAX as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →